Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Explore practical smart money moves that can elevate your financial situation in everyday life. Start making informed choices now.
7,101 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Pinterest faces headwinds after a price-target cut to $27. This story outlines three critical steps that could unlock...
Ethereum sits just above $2,100 as on-chain data shows exchange reserves shrinking to levels not seen since 2016, wit...
When markets flipped into risk-off mode, Altria stock closed today higher as investors sought steady income. This art...
Amazon's latest move highlights a broader theme: AI investment can lift near-term costs even as revenue opportunities...
Brokerages launch pilots that allow 13-year-olds to trade stocks with limited parental approval, prompting wide-rangi...
Oil climbs toward the $100-per-barrel level as the Iran conflict enters its fourth week. Traders warn that volatility...
Investors are flocking to renewable energy stocks as policy support and expanding clean-energy projects push the sect...
As 2026 unfolds, investors eye the best blockchain penny stocks for upside amid renewed crypto infrastructure gains. ...
Volatility is rising and daily balance checks may hurt more than help. This piece explains why experts stop checking ...
As recession fears swirl, long-duration U.S. Treasuries offer a potential ballast. The TLT ETF is drawing interest as...
Investors are watching whether NVIDIA back business China could unlock a new revenue stream. This analysis covers sce...